Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 72 checked references that resolve
resolves10.1080/10408440500534362The Acquisition and Application of Absorption, Distribution, Metabolism, and Excretion (ADME) Data in Agricultural Chemical Safety Assessments
resolves10.3109/03602538409029964Interspecies Comparison of In Vivo Caffeine Pharmacokinetics in Man, Monkey, Rabbit, Rat and Mouse
resolves10.1002/bdrb.20288Evaluation of the reproductive and developmental risks of caffeine
resolves10.1089/jcr.2013.0005Caffeine Withdrawal and Dependence: A Convenience Survey Among Addiction Professionals
resolves10.4236/pp.2014.54054Population Pharmacokinetic Pharmacodynamic Modeling of Caffeine Using Visual Analogue Scales
resolves10.1155/2018/9061234Efficacy and Safety of Different Maintenance Doses of Caffeine Citrate for Treatment of Apnea in Premature Infants: A Systematic Review and Meta-Analysis
resolves10.1002/tera.1047Teratogen update: Evaluation of the reproductive and developmental risks of caffeine
resolves10.1136/bmj.313.7069.1358Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: prospective population based study
resolves10.3390/nu8030154Sources of Caffeine in Diets of US Children and Adults: Trends by Beverage Type and Purchase Location
resolves10.1111/j.1528-1167.2009.02268.xA prospective study of smoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adult women: Data from the Nurses’ Health Study II
resolves10.1592/phco.20.7.644.35167Caffeine Citrate for the Treatment of Apnea of Prematurity: A Double‐Blind, Placebo‐Controlled Study
resolves10.1111/j.1750-3841.2010.01561.xCaffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters
resolves10.1093/aje/kws222Coffee, Tea, and Fatal Oral/Pharyngeal Cancer in a Large Prospective US Cohort
resolves10.1038/nn1491Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine
resolves10.1016/j.ygyno.2013.03.014Coffee and caffeine intake and breast cancer risk: An updated dose–response meta-analysis of 37 published studies
resolves10.1093/jat/bkx011Review of Caffeine-Related Fatalities along with Postmortem Blood Concentrations in 51 Poisoning Deaths
resolves10.3945/ajcn.112.038794Associations between polymorphisms in the AHR and CYP1A1-CYP1A2 gene regions and habitual caffeine consumption
resolves10.1111/bcp.13089Systematic review and meta‐analysis of clinical outcomes of early caffeine therapy in preterm neonates
resolves10.3945/an.114.006692Institute of Medicine. 2014. Caffeine in Food and Dietary Supplements: Examining Safety—Workshop Summary. Washington, DC: The National Academies Press, 2014
resolves10.1016/0002-9149(87)90842-3Caffeine as a possible cause of ventricular arrhythmias during the healing phase of acute myocardial infarction
resolves10.1016/j.fct.2010.06.019A review of the epidemiologic evidence concerning the reproductive health effects of caffeine consumption: A 2000–2009 update
resolves10.1016/j.lfs.2014.01.083Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: A review
resolves10.1172/JCI110124Tolerance to the humoral and hemodynamic effects of caffeine in man.
resolves10.1016/j.foodres.2019.05.029Drinking for protection? Epidemiological and experimental evidence on the beneficial effects of coffee or major coffee compounds against gastrointestinal and liver carcinogenesis
resolves10.1001/jama.2011.2024Survival Without Disability to Age 5 Years After Neonatal Caffeine Therapy for Apnea of Prematurity
resolves10.1037/a0021651Effects of acute caffeine administration on adolescents.
resolves10.1016/j.fct.2016.06.007Trends and patterns of caffeine consumption among US teenagers and young adults, NHANES 2003–2012
resolves10.3109/15563650.2016.1146740Pharmacokinetic analysis and comparison of caffeine administered rapidly or slowly in coffee chilled or hot versus chilled energy drink in healthy young adults
resolves10.1016/j.fct.2017.04.002Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children
resolves10.1016/S0015-6264(77)80256-3A 2-year feeding study of instant coffees in rats. I. Body weight, food consumption, haematological parameters and plasma chemistry
The 19 references without a DOI — listed, not checked
no DOI — not checkedCaffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies
no DOI — not checkedDietitians of Canada. 2014. Food sources of caffeine. Available: http://www.dietitians.ca/Your-Health/Nutrition-A-Z/Caffeine/Food-Sources-of-Caffeine.aspx [accessed 06/03/2015].
no DOI — not checkedDo energy drinks cause epileptic seizure and ischemic stroke?
no DOI — not checkedScientific opinion on the safety of caffeine
no DOI — not checkedApnea of prematurity: caffeine dose optimization
no DOI — not checkedIARC (1991). Caffeine. In: Coffee, Tea, Mate, Methylxanthines and Methylglyoxal. IARC Working Group, Feb. 27-Mar. 6, 1990, Lyon, France. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 51). World Health Organization (WHO), Lyon, France: International Agency for Research on Cancer (IARC), pp. 291-390.
no DOI — not checkedIARC (2018). Drinking Coffee, Mate, and Very Hot Beverages. Expert Opinions of IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, May 24-31, 2016, Lyon, France. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 116). Lyon, France: International Agency for Research on Cancer (IARC).
no DOI — not checkedCaffeine for the sustainment of mental task performance: fomulations for military operations
no DOI — not checkedIPCS. 1998. Caffeine.
no DOI — not checkedThe relationship between tea and coffee consumption and glioma: a systematic review
no DOI — not checked10.1016/B978-0-12-821038-3.00032-X_bib60
no DOI — not checkedOECD-SIDS. 2002. Organisation for economic co-operation and development screening information dataset (OECD SIDS). Initial assessment profile: Caffeine. Available at www.chemunepch/irptc/sids/OECDSIDS/CAFFEINE.pdf.
no DOI — not checkedSCF (Scientific Committee on Food), 1999. Opinion on Caffeine, Taurine and D-Glucurono -γ-Lactone as constituents of so-called “energy” drinks. 15 pp.
no DOI — not checkedCaffeinated energy drink intoxication
no DOI — not checkedUS FDA (2018a). FDA Warns Companies to Stop Selling Dangerous and Illegal Pure and Highly Concentrated Caffeine Products. Silver Spring (MD): U.S. Food and Drug Administration (U.S. FDA).
no DOI — not checkedPart 340—Stimulant drug products for over-the-counter human use. §340.50—Labeling of stimulant drug products
no DOI — not checkedUS FDA, 2012 FDA, 2012. Letter from Jeanne Ireland, Assistant Commissioner for Legislation to the Honorable Richard J. Durbin, Senator dated August 10, 2012 [Re: Letter of April 3, 2012 Expressing Concern About Potential Safety Issues Associated With the Consumption of so-called “Energy Drinks”]. Available from: http://www.durbin.senate.gov/imo/media/doc/09112012FDA.pdf.
no DOI — not checkedUS FDA, 21 CFR 340.50. Part 340—stimulant drug products for over-the-counter human use. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=340.50.
no DOI — not checkedUS FDA, Oakridge National Laboratory. 2010. Caffeine intake by the U.S population.
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.